IMVT
Immunovant, Inc. · Healthcare
CEO Peter Salzmann sold $262K of Immunovant, Inc.
Sold$261,845
$28.79Price
9,095Shares
−1%Stake
What IMVT did after the filing
- The stock from Fri, Oct 18 close, $29.47
- −2.3%
- S&P 500, same days
- +3.3%
Measured over 30 trading days, to the Dec 2 close.
Traded Wed, Oct 16. Filed Fri, Oct 18, 12:31 PM ET, during the session. Returns use the Oct 18 close and the Dec 2 close. Not investment advice.